Table 1.
Demographic features, pulmonary function test values, radiological assessment, and biomarker assessment in sarcoidosis population.
| No. | 74 |
| Male (%) | 27 (36) |
| Age (years) | 44.6 ± 7.7 |
| Smoking status | |
| Former (%) | 21 (28) |
| Current (%) | 6 (8) |
| Never (%) | 46 (62) |
| Radiological stages | |
| 0 | 0 |
| 1 | 7 |
| 2 | 33 |
| 3 | 12 |
| 4 | 22 |
| Pulmonary function tests | |
| FEV1 % | 94.4 ± 22.06 |
| FVC % | 104.3 ± 20.2 |
| TLC % | 107.7 ± 23.2 |
| DLCO %∗ | 77.4 ± 17.6 |
| Laboratory markers | |
| ACE (U/l) | 76.1 ± 41.9 |
| Lysozyme (mg/l) | 5.4 ± 2.5 |
| Chitotriosidase (nmol/ml/h) | 105.6 ± 135.8 |
| KL-6 (U/ml) | 573 ± 480.7 |
Data are expressed as media ± SD. ∗Parameter available only in 63 patients.